Rolph Timothy
Officer at AKRO
- Sold, on record
- $18.9M
- Dollars the filings state
- Form 4 sales
- 30
- Latest Oct 7, 2025
- Form 144 notices
- 8
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AKROAkero Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AKRONo planJun 18, 2025 2025
Sold 1,129 shares at $54.84 ($62k)
Rolph Timothy, Chief Scientific Officer
No 10b5-1 planSold 0.7% of holdings ($9.2M position)166,234 shares left0.3x usual sizeFiling
- 2 Form 144 notice AKRONoticeJul 7, 2025 +19 days
Filed to sell 56,250 shares ($2.9M)
Rolph Timothy, Officer
10b5-1 plan14.8x usual sizeFiling
- 3 Form 4 sale AKROUnusualJul 7, 2025 same day
Sold 12,500 shares at $51.09 ($639k)
Rolph Timothy, Chief Scientific Officer
10b5-1 planSold 7% of holdings ($9.2M position)167,124 shares left3.3x usual sizeFollows a Form 144Filing
- 4 Form 4 sale AKRORoutineAug 5, 2025 +29 days
Sold 12,500 shares at $49.30 ($616k)
Rolph Timothy, Chief Scientific Officer
10b5-1 planSold 7% of holdings ($8.9M position)167,124 shares left2.9x usual sizeFollows a Form 144Filing
- 5 Form 4 sale AKRORoutineSep 8, 2025 +34 days
Sold 12,500 shares at $44.17 ($552k)
Rolph Timothy, Chief Scientific Officer
10b5-1 planSold 7% of holdings ($7.9M position)167,124 shares left2.6x usual sizeFollows a Form 144Filing
- 6 Form 4 sale AKRONo planSep 11, 2025 +3 days
Sold 553 shares at $43.02 ($24k)
Rolph Timothy, Chief Scientific Officer
No 10b5-1 planSold 0.3% of holdings ($7.2M position)166,571 shares left0.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice AKRONoticeOct 7, 2025 +26 days
Filed to sell 56,369 shares ($2.6M)
Rolph Timothy, Officer
10b5-1 plan10.2x usual sizeFiling
- 8 Form 4 sale AKRORoutineOct 7, 2025 same day
Sold 12,500 shares at $46.08 ($576k)
Rolph Timothy, Chief Scientific Officer
10b5-1 planSold 7% of holdings ($8.3M position)166,571 shares left2.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (38)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Oct 9, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 12,500 | $576k | 7.0% | Routine | SEC |
| Oct 7, 2025 | Oct 7, 2025 | AKRO | Officer | Form 144 notice | 56,369 | $2.6M | Notice | SEC | |
| Sep 11, 2025 | Sep 12, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 553 | $24k | 0.3% | No plan | SEC |
| Sep 8, 2025 | Sep 10, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 12,500 | $552k | 7.0% | Routine | SEC |
| Aug 5, 2025 | Aug 7, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 12,500 | $616k | 7.0% | Routine | SEC |
| Jul 7, 2025 | Jul 9, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 12,500 | $639k | 7.0% | Unusual | SEC |
| Jul 7, 2025 | Jul 7, 2025 | AKRO | Officer | Form 144 notice | 56,250 | $2.9M | Notice | SEC | |
| Jun 18, 2025 | Jun 20, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 1,129 | $62k | 0.7% | No plan | SEC |
| Jun 10, 2025 | Jun 12, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 2,358 | $127k | 1.4% | No plan | SEC |
| Jun 6, 2025 | Jun 9, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 37,500 | $2M | 18.1% | Unusual | SEC |
| May 6, 2025 | May 8, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 12,500 | $543k | 6.9% | Unusual | SEC |
| May 6, 2025 | May 6, 2025 | AKRO | Officer | Form 144 notice | 50,000 | $2M | Notice | SEC | |
| Apr 24, 2025 | Apr 28, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 6,250 | $256k | 3.6% | Routine | SEC |
| Apr 7, 2025 | Apr 10, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 6,250 | $224k | 3.6% | Routine | SEC |
| Mar 12, 2025 | Mar 14, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 516 | $23k | 0.3% | No plan | SEC |
| Mar 5, 2025 | Mar 7, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 12,500 | $557k | 6.8% | Unusual | SEC |
| Feb 5, 2025 | Feb 7, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 18,750 | $1.1M | 9.9% | Unusual | SEC |
| Jan 27, 2025 | Jan 29, 2025 | AKRO | Chief Scientific Officer | Form 4 sale | 31,250 | $1.7M | 15.5% | Unusual | SEC |
| Jan 27, 2025 | Jan 27, 2025 | AKRO | Officer | Form 144 notice | 68,750 | $3.9M | Notice | SEC | |
| Dec 17, 2024 | Dec 18, 2024 | AKRO | Chief Scientific Officer | Form 4 sale | 3,800 | $118k | 2.1% | Routine | SEC |
| Dec 10, 2024 | Dec 12, 2024 | AKRO | Chief Scientific Officer | Form 4 sale | 4,818 | $149k | 2.6% | Routine | SEC |
| Dec 10, 2024 | Dec 10, 2024 | AKRO | Officer | Form 144 notice | 25,000 | $770k | Notice | SEC | |
| Sep 10, 2024 | Sep 13, 2024 | AKRO | Chief Scientific Officer | Form 4 sale | 537 | $14k | 0.3% | No plan | SEC |
| Jun 11, 2024 | Jun 13, 2024 | AKRO | Chief Scientific Officer | Form 4 sale | 2,380 | $54k | 1.3% | No plan | SEC |
| Mar 13, 2024 | Mar 15, 2024 | AKRO | Chief Scientific Officer | Form 4 sale | 619 | $18k | 0.3% | No plan | SEC |
| Dec 14, 2023 | Dec 18, 2023 | AKRO | Chief Scientific Officer | Form 4 sale | 514 | $11k | 0.3% | No plan | SEC |
| Sep 13, 2023 | Sep 25, 2023 | AKRO | Chief Scientific Officer | Form 4 sale | 531 | $27k | 0.4% | No plan | SEC |
| Jun 26, 2023 | Jun 26, 2023 | AKRO | Officer | Form 144 notice | 40,000 | $2M | Notice | SEC | |
| Jun 16, 2023 | Jun 21, 2023 | AKRO | Chief Scientific Officer | Form 4 sale | 78,200 | $4.3M | 34.1% | Unusual | SEC |
| Jun 16, 2023 | Jun 16, 2023 | AKRO | Officer | Form 144 notice | 40,000 | $2.2M | Notice | SEC | |
| Jun 16, 2023 | Jun 16, 2023 | AKRO | Affiliate | Form 144 notice | 38,200 | $2.1M | Notice | SEC | |
| Jun 13, 2023 | Jun 15, 2023 | AKRO | Chief Scientific Officer | Form 4 sale | 509 | $28k | 0.3% | Routine | SEC |
| Dec 29, 2022 | Dec 30, 2022 | AKRO | Chief Scientific Officer | Form 4 sale | 22,016 | $1.1M | 10.4% | Plan not stated | SEC |
| Nov 16, 2022 | Nov 16, 2022 | AKRO | Chief Scientific Officer | Form 4 sale | 7,085 | $321k | 3.7% | Plan not stated | SEC |
| Oct 26, 2022 | Oct 27, 2022 | AKRO | Chief Scientific Officer | Form 4 sale | 15,415 | $695k | 7.5% | Plan not stated | SEC |
| Oct 6, 2022 | Oct 7, 2022 | AKRO | Chief Scientific Officer | Form 4 sale | 22,500 | $884k | 10.8% | Plan not stated | SEC |
| Sep 30, 2022 | Oct 4, 2022 | AKRO | Chief Scientific Officer | Form 4 sale | 45,000 | $1.5M | 18.5% | Plan not stated | SEC |
| Sep 13, 2022 | Sep 15, 2022 | AKRO | Chief Scientific Officer | Form 4 sale | 22,500 | $657k | 9.1% | Plan not stated | SEC |